314 related articles for article (PubMed ID: 26692014)
21. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
Cao Y; Karsten U
Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy.
Osinaga E; Bay S; Tello D; Babino A; Pritsch O; Assemat K; Cantacuzene D; Nakada H; Alzari P
FEBS Lett; 2000 Mar; 469(1):24-8. PubMed ID: 10708749
[TBL] [Abstract][Full Text] [Related]
24. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
[TBL] [Abstract][Full Text] [Related]
25. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
26. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
27. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
[TBL] [Abstract][Full Text] [Related]
28. Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition.
Madariaga D; Martínez-Sáez N; Somovilla VJ; Coelho H; Valero-González J; Castro-López J; Asensio JL; Jiménez-Barbero J; Busto JH; Avenoza A; Marcelo F; Hurtado-Guerrero R; Corzana F; Peregrina JM
ACS Chem Biol; 2015 Mar; 10(3):747-56. PubMed ID: 25457745
[TBL] [Abstract][Full Text] [Related]
29. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
[TBL] [Abstract][Full Text] [Related]
30. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
[TBL] [Abstract][Full Text] [Related]
31. A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells.
Leiria Campo V; Riul TB; Oliveira Bortot L; Martins-Teixeira MB; Fiori Marchiori M; Iaccarino E; Ruvo M; Dias-Baruffi M; Carvalho I
Chembiochem; 2017 Mar; 18(6):527-538. PubMed ID: 28068458
[TBL] [Abstract][Full Text] [Related]
32. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
Dai J; Allard WJ; Davis G; Yeung KK
Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
Inoue M; Yamashina I; Nakada H
Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
[TBL] [Abstract][Full Text] [Related]
34. Fast epitope mapping for the anti-MUC1 monoclonal antibody by combining a one-bead-one-glycopeptide library and a microarray platform.
Garcia-Martin F; Matsushita T; Hinou H; Nishimura S
Chemistry; 2014 Nov; 20(48):15891-902. PubMed ID: 25303614
[TBL] [Abstract][Full Text] [Related]
35. An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer.
Pan D; Tang Y; Tong J; Xie C; Chen J; Feng C; Hwu P; Huang W; Zhou D
Cancer Med; 2020 Dec; 9(24):9529-9540. PubMed ID: 33084221
[TBL] [Abstract][Full Text] [Related]
36. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
[TBL] [Abstract][Full Text] [Related]
37. Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.
Marcelo F; Supekar N; Corzana F; van der Horst JC; Vuist IM; Live D; Boons GPH; Smith DF; van Vliet SJ
J Biol Chem; 2019 Jan; 294(4):1300-1311. PubMed ID: 30504228
[TBL] [Abstract][Full Text] [Related]
38. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
39. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
40. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
